Literature DB >> 14559925

Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies.

James W Anderson1, Cyril W C Kendall, David J A Jenkins.   

Abstract

Obesity is a major risk factor for development of diabetes, and excessive energy intake is a major contributor to poor glycemic control in Type 2 diabetes. The impact of obesity on risk for diabetes as well as coronary heart disease (CHD) risk factors and the benefits of weight loss in decreasing risk for developing diabetes and improving glycemia and CHD risks were reviewed. A systematic review of the medical literature to assess the impact of obesity and weight gain on risk for diabetes and CHD was done. We performed a meta-analysis of the effects of weight loss for obese diabetic individuals. Controlled clinical trials assessing lifestyle changes on risk for developing diabetes and weight loss effects on glycemia and CHD risk factors were reviewed. Obesity and weight gain can increase risk for diabetes by greater than ninetyfold and CHD by about sixfold. Very-low-energy diets (VLED) decrease fasting plasma glucose values by approximately 50% within two weeks and these changes are sustained with continued energy restriction. Twelve weeks of energy-restricted diets were associated with these significant decreases: body weight, 9.6%; fasting plasma glucose, 25.7%; serum cholesterol, 9.2%; serum triglycerides, 26.7%; systolic blood pressure, 8.1%; and diastolic blood pressure, 8.6%. Larger weight losses were associated with larger reductions in these values. The reviewed data suggest that US health care providers should endorse the American Heart Association's and European diabetes associations' recommendations that diabetic persons achieve and maintain a BMI of <or=25 kg/m(2). Weight management may be the most important therapeutic task for most obese Type 2 diabetic individuals.

Entities:  

Mesh:

Year:  2003        PMID: 14559925     DOI: 10.1080/07315724.2003.10719316

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  112 in total

Review 1.  Post-transcriptional regulation in metabolic diseases.

Authors:  Wook Kim; Eun Kyung Lee
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

2.  Effect of the estrous cycle and surgical ovariectomy on energy balance, fuel utilization, and physical activity in lean and obese female rats.

Authors:  Erin D Giles; Matthew R Jackman; Ginger C Johnson; Pepper J Schedin; Jordan L Houser; Paul S MacLean
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-10-06       Impact factor: 3.619

3.  Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  S E Inzucchi; R M Bergenstal; J B Buse; M Diamant; E Ferrannini; M Nauck; A L Peters; A Tsapas; R Wender; D R Matthews
Journal:  Diabetologia       Date:  2012-04-20       Impact factor: 10.122

Review 4.  The role of diet and lifestyle in primary, secondary, and tertiary diabetes prevention: a review of meta-analyses.

Authors:  Theodora Psaltopoulou; Ioannis Ilias; Maria Alevizaki
Journal:  Rev Diabet Stud       Date:  2010-05-10

Review 5.  Glycemic control and weight reduction without causing hypoglycemia: the case for continued safe aggressive care of patients with type 2 diabetes mellitus and avoidance of therapeutic inertia.

Authors:  Stanley S Schwartz; Benjamin A Kohl
Journal:  Mayo Clin Proc       Date:  2010-11-24       Impact factor: 7.616

6.  Eating behavior affects quality of life in type 2 diabetes mellitus.

Authors:  F Cerrelli; R Manini; G Forlani; L Baraldi; N Melchionda; G Marchesini
Journal:  Eat Weight Disord       Date:  2005-12       Impact factor: 4.652

7.  Adiposopathy: treating pathogenic adipose tissue to reduce cardiovascular disease risk.

Authors:  Harold Bays; Helena W Rodbard; Alan Bruce Schorr; J Michael González-Campoy
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

Review 8.  Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review.

Authors:  Andrew S Bomback; Philip J Klemmer
Journal:  Am J Nephrol       Date:  2009-03-20       Impact factor: 3.754

9.  Pre-pregnancy obesity and maternal nutritional biomarker status during pregnancy: a factor analysis.

Authors:  Laura E Tomedi; Chung-Chou H Chang; P K Newby; Rhobert W Evans; James F Luther; Katherine L Wisner; Lisa M Bodnar
Journal:  Public Health Nutr       Date:  2013-03-25       Impact factor: 4.022

10.  The endocanabinnoid system and diabetes - critical analyses of studies conducted with rimonabant.

Authors:  Ada Letícia B Murro
Journal:  Diabetol Metab Syndr       Date:  2009-10-16       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.